Sea Crest Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sea Crest Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $37,287 - $50,241	68 New	68 $40,000
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $271,196 - $344,724	-567 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $61,012 - $73,719	112 Added 24.62%	567 $317,000
Q2 2020 Jul 27, 2020	BUY	$493.32 - $643.92 $224,460 - $292,983	455 New	455 $284,000
Q2 2019 Jul 19, 2019	SELL	$299.6 - $414.82 $17,376 - $24,059	-58 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$372.08 - $439.57 $5,209 - $6,153	-14 Reduced 19.44%	58 $24,000
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $6,380 - $7,657	-19 Reduced 20.88%	72 $27,000
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $3,511 - $4,085	-10 Reduced 9.9%	91 $37,000
Q2 2018 Aug 03, 2018	BUY	$284.6 - $344.99 $3,415 - $4,139	12 Added 13.48%	101 $35,000
Q1 2018 Apr 20, 2018	BUY	$315.82 - $393.78 $3,789 - $4,725	12 Added 15.58%	89 $31,000
Q4 2017 Feb 02, 2018	BUY	$358.63 - $469.95 $27,614 - $36,186	77	77 $29,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.